A comparative evaluation of transrectal versus transperineal prostate biopsy in safety
Zhang Peixini1 Jia Hongliang1 Aniwan2 Pu Chunlin1 Chen Jiansen1 Wen Bin1 Li Ming1 Li Yun3
1Department of Urology, the People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang 830001, China; 2Department of Pathology, the People's Hospital of Xinjiang Uygur Autonomous Region; 3Department of Urology, the People's Hospital of Xinyu
Abstract:To compare the safety between ultrasound-guided transrectal (TR) and transperineal (TP) approaches in prostate biopsy for prostate cancer detection. Methods: A retrospective study was conducted on 780 consecutive suspected prostate cancer patients initially given ultrasound-guided transrectal (n=412) and trasperineal (n=368) prostate biopsy, and the biopsy results and post-biopsy complications were compared between TR and TP. Results: The positive incidence in TR and TP groups was not significantly different (P=0.846). The age, prostate volume, PSA value, body mass index and digital examination between two groups showed no significant difference, and there was significant difference in operation time between two groups. The positive incidence between two groups according to PSA valus (PSA≤10 μg/L or >10 μg/L) was not significantly different. The positive incidence between two groups was significantly different while the prostate volume was greater than 50 mL. The complication rate in pain, hematuria, hematochezia, fever and bacteriaemia between two groups was significantly different. Conclusions: TR and TP are safe and effective for the diagnosis of prostate tumour, owing to the comparative tumor detection rate and few complication rate, and the option between TR and TP in clinical practice depends on the certain circumstances of each patient.
张培新 贾宏亮 艾尼娃 蒲春林 陈建森 文彬 李鸣 李赟. 经会阴及经直肠前列腺穿刺活检安全性比较分析[J]. 微创泌尿外科杂志, 2016, 5(5): 281-284.
Zhang Peixini Jia Hongliang Aniwan Pu Chunlin Chen Jiansen Wen Bin Li Ming Li Yun. A comparative evaluation of transrectal versus transperineal prostate biopsy in safety. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2016, 5(5): 281-284.
[1]Hara R, Jo Y, Fujii T, et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology, 2008,71(2):191-195. [2]那彦群,叶章群,孙光.中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2013:63-64. [3]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin, 2016,66(1):7-30. [4]Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol, 2013,64(6):876-892. [5]Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 1989,142(1):71-75. [6]Kang SG, Tae BS, Min SH, et al. Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia. Asian J Androl, 2011,13(5):724-727. [7]Emiliozzi P, Corsetti A, Tassi B, et al. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology, 2003,61(5):961-966. [8]Cerruto MA, Vianello F, D'Elia C, et al. Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: a comparative evaluation at the same institution. Arch Ital Urol Androl, 2014,86(4):284-287. [9]Hu Y, Ahmed HU, Carter T, et al. A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy. BJU Int, 2012,110(6):812-820. [10]Shen PF, Zhu YC, Wei WR, et al. The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl, 2012,14(2):310-315. [11]Rosario DJ, Lane JA, Metcalfe C, et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ, 2012,344:d7894. [12]Pinkhasov GI, Lin YK, Palmerola R, et al. Complications following prostate needle biopsy requiring hospital admission or emergency department visits-experience from 1000 consecutive cases. BJU Int, 2012,110(3):369-374. [13]Lee SH, Chen SM, Ho CR, et al. Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer. Chang Gung Med J, 2009,32(6):623-627. [14]Wagenlehner FM, van Oostrum E, Tenke P, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol, 2013,63(3):521-527. [15]Zaytoun OM, Vargo EH, Rajan R, et al. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology, 2011,77(5):1035-1041. [16]Crawford ED, Rove KO, Barqawi AB, et al. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate, 2013,73(7):778-787. [17]Utrera NM, lvarez MB, Polo JM, et al. Infectious complications after transrectal ultrasound-guided prostatic biopsy. Analysis of our experience. Arch Esp Urol, 2011,64(7):605-610. [18]Udeh EI, Amu OC, Nnabugwu II, et al. Transperineal versus transrectal prostate biopsy: our findings in a tertiary health institution. Niger J Clin Pract, 2015,18(1):110-114. [19]Volanis D, Neal DE, Warren AY, et al. Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature. BJU Int, 2015,115(5):698-704. [20]陈锐,谢立平,周利群,等.中国前列腺癌联盟成员医院前列腺穿刺活检现状的调查报告.中华泌尿外科杂志,2015,36(5):342-345.